Skip to content

Drug interactions

Doxorubicin + Lonafarnib

Severity: Moderate

Doxorubicin and Lonafarnib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a strong CYP3A inhibitor and may raise doxorubicin exposure, increasing myelosuppression and cardiotoxicity. The listed direction, doxorubicin raising lonafarnib, is unlikely since doxorubicin is not a meaningful CYP3A inhibitor.

What this interaction means in plain words

Doxorubicin and Lonafarnib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Doxorubicin belongs to Oncology; Lonafarnib belongs to Miscellaneous.

Evidence level: Low

Why it happens

Lonafarnib inhibits CYP3A4, potentially reducing doxorubicin metabolism.

What to do

Monitor blood counts, ECG and cardiac function during co-administration. Consider doxorubicin dose reduction if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Doxorubicin and Lonafarnib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Doxorubicin with Lonafarnib?

MediHelp rates the interaction as moderate. Doxorubicin and Lonafarnib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lonafarnib is a strong CYP3A inhibitor and may raise doxorubicin exposure, increasing myelosuppression and cardiotoxicity. The listed direction, doxorubicin raising lonafarnib, is unlikely since doxorubicin is not a meaningful CYP3A inhibitor.

How serious is the interaction between Doxorubicin and Lonafarnib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts, ECG and cardiac function during co-administration. Consider doxorubicin dose reduction if toxicity occurs.

What other medicines interact with Doxorubicin?

MediHelp also lists interactions of Doxorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cobicistat. The full list is on the Doxorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in